Alternatives to Beam Therapeutics

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Developing gene editing therapies to lower cholesterol.

Developing polymer-based nanoparticles for targeted gene therapy delivery.

A clinical-stage biotechnology company developing in vivo gene editing therapies.

Cassidy Bio is an AI-driven company accelerating gene editing therapeutic development with bespoke solutions for faster, smarter R&D decisions.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Developing engineered biologics to harness the immune system for disease treatment.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Biotech company developing next-generation gene writing tools for advanced therapies.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

AI-driven diagnostics that convert medical images into actionable genomic insights for faster cancer treatment decisions.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Drug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform.

Scalable, one-time curative in-vivo gene editing therapies.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Genomic data analysis platform for rare diseases and cancer.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Leveraging the adaptive immune system to diagnose and treat disease.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-powered platform for designing novel molecular structures for new medicines.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Developing novel therapeutics for rare genetic diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Develops antibody-drug conjugates (ADCs) for targeted cancer therapy.

Clinical-stage precision medicine company using protein motion insights for drug discovery.